Heterologous versus homologous boosting regimens elicit qualitatively distinct, BA.5 cross reactive T cells in transplant recipientsElizabeth A. Thompson, Andrea L. Cox, Joel N. Blankson et al.|The Journal of Immunology|2023Cited by 0